Apr 23, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has granted Eli Lilly's motion for a preliminary injunction related to Teva's abbreviated new drug application to market its generic version of Evista Tablets. Teva plans to appeal the decision.
The details can be read here.
No comments:
Post a Comment